Prairie Heart Institute is a clinical research site located in Springfield, Illinois, United States 62701.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
Prairie Heart Institute has participated in 11 clinical trials with 3 currently active.
Therapeutic areas: Hypertension, Paroxysmal Atrial Fibrillation, Medication Non-Adherence.
Sponsors: Medtronic Vascular, CardioFocus, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Prairie Heart Institute has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Prairie Heart Institute has 11 clinical trials on record, with 3 currently active. Their work covers Hypertension, Paroxysmal Atrial Fibrillation, Medication Non-Adherence.
Yes — Prairie Heart Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.